Type your drug name (like Atorvastatin, Sildenafil, etc)
Cancel
Advertisement
Invokamet Coupon - Invokamet 150mg/1000mg tablet
Invokamet
CANAGLIFLOZIN; METFORMIN is a combination of 2 medicines used to treat type 2 diabetes. This medicine lowers blood sugar. Treatment is combined with a balanced diet and exercise. The lowest GoodRx price for the most common version of Invokamet is around $469.88, 18% off the average retail price of $573.47. Compare SGLT2 inhibitor / biguanide combinations.
Prescription Settings
brand
tablet
150mg/1000mg
60 tablets
Invokamet Coupon - Invokamet 150mg/1000mg tablet
Invokamet(brand)
tablet
150mg/1000mg
60 tablets
Insurance Coverage: Many major insurance plans no longer cover Invokamet. Learn More

Invokamet Latest News

Get the latest updates on this drug from the GoodRx medical team

FDA Warns of Serious Genital Infection Linked to SGLT2 Inhibitors for Diabetes

Roni Shye
Roni Shye -

Just last week, the Food and Drug Administration (FDA) released a new warning for SGLT2 inhibitors, a class of drugs used to lower blood sugar in adults with type 2 diabetes. According to the FDA, a serious bacterial infection known as necrotizing fasciitis has been reported in the genital area of some patients taking SGLT2 inhibitors. While this condition is rare and only 12 cases have been confirmed since 2013, necrotizing fasciitis spreads rapidly and can be deadly. See More

Generic Jardiance Is 5 Years Away (At Least) — Here Are 5 Ways To Save Now

Tori Marsh
Tori Marsh -

Well-known for treating type 2 diabetes, Jardiance can also reduce the risk of a cardiovascular event by 38%—but it’s expensive. A 30-day supply costs well over $500, and many insurance plans won’t cover it. Luckily, there are ways for you to save as much as 100% off the cash price.

How much does Jardiance cost?

As of August 2018, the cash price for Jardiance is over $500 for 30 tablets. GoodRx discounts can help reduce this price a bit—to around $450—but that’s still way too much for most people. See More

Updated FDA Safety Alert: Invokana and Invokamet for Diabetes

Roni Shye
Roni Shye -

On May 16th, 2017, the FDA issued an update on canagliflozin-containing medications, like Invokana and Invokamet, as part of a year-long ongoing review.

This update is the result of new data from the CANVAS and CANVAS-R clinical trials. This research showed that leg and foot amputations occurred two times more often in patients treated with canagliflozin than in patients who were given a placebo sugar pill. See More

New FDA Safety Alert: Invokana and Farxiga for Diabetes

Roni Shye
Roni Shye -

In June 2016, the FDA issued a safety alert for canagliflozin (Invokana, Invokamet), used to treat type 2 diabetes.

Now, another warning has been issued, for Invokana and Invokamet along with another similar diabetes medication, dapagliflozin (Farxiga and Xigduo XR).

According to the FDA, canagliflozin and dapagliflozin may cause an increased risk of acute kidney injury. The previous warning for canagliflozin was for an increased risk of foot and leg amputations—all serious stuff. See More

FDA Safety Alert: Invokana and Invokamet for Diabetes

Roni Shye
Roni Shye -

The FDA has issued a safety alert for medications containing canagliflozin, a newer drug used to treat type 2 diabetes.

According to the FDA, medications containing canagliflozin (Invokana and Invokamet) may cause an increased risk of leg and foot amputations.

Do diabetics already have an increased risk of leg and foot amputations?

Yes. Diabetics have a higher risk of leg and foot amputations compared to a person who does not have diabetes. See More

50+ Drugs Dropped by Insurance in 2016, Including Viagra and Qsymia

Elizabeth Davis
Elizabeth Davis -

It’s that time again—the new lists of covered and excluded drugs on next year’s insurance plans are out, and it doesn’t look great. For many Americans with health insurance, more than 50 popular brand-name and generic drugs may no longer be covered starting in January 2016.

Express Scripts and Caremark, companies that handles pharmacy benefits for more than 200 million Americans, are removing about 20 – 30 drugs each from their national preferred formularies at the end of 2015. See More

Ketoacidosis Warning Issued for New Diabetes Meds

Roni Shye
Roni Shye -

On May 15, 2015, the FDA issued a warning for the newest class of diabetes medications, SGLT2 inhibitors.

According to the FDA, the medications in this class may lead to a serious and life-threatening condition known as ketoacidosis.

Which medications are considered SGLT2 inhibitors?

These medications also contain SGLT2 inhibitors in combination with other active ingredients:

What should I do if I am taking one of these medications?

If you are taking one of the medications listed above DO NOT stop your medication without talking to your doctor. See More

Copyright ©2018 GoodRx, Inc.
GoodRx is not sponsored by or affiliated with any of the pharmacies identified in its price comparisons. All trademarks, brands, logos and copyright images are property of their respective owners and rights holders and are used solely to represent the products of these rights holders. This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment.
In all states except Tennessee, GoodRx is considered a marketer of prescription discount cards, and is not required to register as a discount card provider. In Tennessee, GoodRx is registered as a Prescription Drug Discount Plan Operator.
LegitScript SealNABP SealBBB Seal